Clinical trial
Rubidium Elution System Performance Testing
NCT02117284 is registered in ClinicalTrials.gov with Ottawa Heart Institute Research Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rubidium Elution System Performance Testing
- Lead sponsor
- Ottawa Heart Institute Research Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- September 30, 2018
- Enrollment
- 15,800 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.